New Invention: “Effect of Achillea fragrantissima extracts on cancer cell lines” A new source for Leukemia treatment.

Three researchers from Saudi Arabia have presented at the Geneva Invention Fair 2013 their  invention: „ Effect of Achillea fragrantissima extracts on cancer  cell lines” which is new source for Leukemia treatment.

Effects of isolated compounds of Achilea fragrantissima extract on animals:

Five compounds were isolated from the extract using  chromatography (CC) and preparative  chromatography (TLC) named as P1, P2, P3, P4 and P5 . The structure of the isolated compounds was confirmed by spectroscopy means.

In distinct contrast, animals treated for similar lengths of time with plant extract or isolated compounds survived at least six times longer than the various control animals . In addition , animals receiving plant extract and/or isolated compounds had significantly less side effects  most frequently, manifesting leukemic cell infiltration, and the central nervous system and others.  These results suggest that Achillea fragranntissima  methanolic  extract and isolated compounds may be efficacious  for the treatment of human Leukemia in vivo , and by analogy , for the treatment of other human neoplasias.

This invention has a potential for broad international application and its application can have very positive  effects in Leukemia treatment.. The inventors are interested in commercialization of their invention, seeking appropriate interested manufacturer.

EPO Patent Registration Services and Consulting GmbH has made direct contact with the inventors and has information about the invention. In case of interest, the interested parties for the invention can contact EPO Patent Registration at the following Email address: Email: epo@epo-prs.de